Koninklijke Philips NV ADR (PHG) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Koninklijke Philips NV ADR stock (PHG) is currently trading at $27.44. Koninklijke Philips NV ADR PE ratio is 24.98. Koninklijke Philips NV ADR PS ratio (Price-to-Sales) is 1.44. Analyst consensus price target for PHG is $35.15. WallStSmart rates PHG as Underperform.
- PHG PE ratio analysis and historical PE chart
- PHG PS ratio (Price-to-Sales) history and trend
- PHG intrinsic value — DCF, Graham Number, EPV models
- PHG stock price prediction 2025 2026 2027 2028 2029 2030
- PHG fair value vs current price
- PHG insider transactions and insider buying
- Is PHG undervalued or overvalued?
- Koninklijke Philips NV ADR financial analysis — revenue, earnings, cash flow
- PHG Piotroski F-Score and Altman Z-Score
- PHG analyst price target and Smart Rating
Koninklijke Philips NV ADR
📊 No data available
Try selecting a different time range
PHG Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Koninklijke Philips NV ADR (PHG)
PHG trades 341% above its Graham fair value of $7.28, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Koninklijke Philips NV ADR (PHG) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in market cap, peg ratio, price/sales. Concerns around return on equity and revenue growth. Fundamentals are solid but monitor weak areas for improvement.
Koninklijke Philips NV ADR (PHG) Key Strengths (4)
Growing significantly faster than its price suggests
Large-cap company with substantial market presence
Paying $1.44 for every $1 of annual revenue
Trading at 1.99x book value, attractively priced
Supporting Valuation Data
Koninklijke Philips NV ADR (PHG) Areas to Watch (6)
Earnings declining -0.50%, profits shrinking
Revenue growing slowly at 1.10% annually
Very low institutional interest at 5.27%
Low profitability relative to shareholder equity
Thin operating margins with cost pressures present
Thin profit margins with limited profitability
Koninklijke Philips NV ADR (PHG) Detailed Analysis Report
Overall Assessment
This company scores 51/100 in our Smart Analysis, earning a C- grade. Out of 10 metrics analyzed, 4 register as strengths (avg 8.8/10) while 6 fall into concern territory (avg 2.5/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on PEG Ratio, Market Cap, Price/Sales. Valuation metrics including PEG Ratio (0.36), Price/Sales (1.44), Price/Book (1.99) suggest the stock is attractively priced.
The Bear Case
The primary concerns are EPS Growth, Revenue Growth, Institutional Own.. Growth concerns include Revenue Growth at 1.10%, EPS Growth at -0.50%, which may limit upside. Profitability pressure is visible in Return on Equity at 7.82%, Operating Margin at 10.70%, Profit Margin at 5.02%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether EPS Growth improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 7.82% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 1.10% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (PEG Ratio, Market Cap) and negatives (EPS Growth, Revenue Growth). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
PHG Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
PHG's Price-to-Sales ratio of 1.44x sits near its historical average of 1.34x (67th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 44% below its historical high of 2.55x set in Sep 2018, and 140% above its historical low of 0.6x in Feb 2009. Over the past 12 months, the PS ratio has compressed from ~1.7x as trailing revenue scaled faster than the stock price.
WallStSmart Analysis Synopsis
Data-driven financial summary for Koninklijke Philips NV ADR (PHG) · HEALTHCARE › MEDICAL DEVICES
The Big Picture
Koninklijke Philips NV ADR is in a high-growth phase, prioritizing rapid expansion over margins. Revenue reached 17.8B with 110% growth year-over-year. Profit margins are thin at 5.0%, typical for companies in this phase that are reinvesting heavily in growth.
Key Findings
Revenue growing at 110% YoY, reaching 17.8B. This pace significantly outperforms most MEDICAL DEVICES peers.
ROE of 782.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
Earnings fell 50% YoY while revenue grew 110%. This gap usually reflects one-time items (tax benefits, write-offs) in the prior period, not an operational decline.
What to Watch Next
Margin expansion: can Koninklijke Philips NV ADR push profit margins above 15% as the business scales?
Growth sustainability: can Koninklijke Philips NV ADR maintain 110%+ revenue growth, or will competition slow it down?
Dividend sustainability with a current yield of 3.8%. Watch payout ratio and free cash flow coverage.
Sector dynamics: monitor MEDICAL DEVICES industry trends, competitive moves, and regulatory changes that could impact Koninklijke Philips NV ADR.
Bottom Line
Koninklijke Philips NV ADR is a high-conviction growth story with revenue accelerating at 110% while profitability is still developing. For growth-oriented investors, the trajectory is compelling. For value investors, the thin 5.0% margins and premium valuation suggest patience until the unit economics mature further.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Data sourced from SEC Form 4 filings
Last updated: 8:25:25 AM
About Koninklijke Philips NV ADR(PHG)
NYSE
HEALTHCARE
MEDICAL DEVICES
USA
Koninklijke Philips NV is a healthcare technology company in North America, Greater China and internationally. The company is headquartered in Amsterdam, the Netherlands.